Friday, June 12, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 176 of 1,261
  1. US 11731099

    Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  2. US 11730178

    Extraction method

    Poly Gain Pte Ltd · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  3. US 11730801

    Live attenuated Zika virus with 3'UTR deletion, vaccine containing and use thereof

    The Board of Regents of the University of Texas System · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  4. US 11730720

    ALK5 inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  5. US 11730767

    Methods, apparatuses and systems for instilling stem cells and pharmaceuticals into the human ventricular system

    Regeneration Biomedical, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  6. US 11730741

    6-chromanol derivatives for use as a medicament

    Sulfateq B.V. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  7. US 11730709

    Compositions and methods for treating severe pain

    Infirst Healthcare Limited · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  8. US 11730723

    Compounds and methods for treating viral infections

    LEXICON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  9. US 11730794

    Use of a VEGF antagonist to treat angiogenic eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  10. US 11730740

    Laureth-4 containing topical formulations

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  11. US 11730705

    Small molecule CMKLR1 antagonists in inflammatory disease

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  12. US 11730150

    Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  13. WO 2023154894

    COMPOSITIONS ET PROCÉDÉS D'IMMUNOTHÉRAPIE ANTICANCÉREUSE

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Aug 17, 2023 · Expires Aug 12, 2043

    granted
  14. US 11725008

    Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases

    The Board of Regents of the University of Texas System · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  15. US 11723929

    Methods of improving cell-based therapy

    The Regents of the University of California · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  16. US 11725005

    Compositions and methods for inhibiting kinases

    Inhibikase Therapeutics, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  17. US 11723885

    Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

    Acurx Pharmaceuticals, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  18. US 11723762

    LIDAR based 3-D imaging with far-field illumination overlap

    VELODYNE LIDAR, INC. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  19. US 11723635

    Devices and methods for umbilical cord processing

    The Board of Regents of the University of Texas System · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  20. US 11723982

    Methods of treating an ocular disease or disorder

    The Regents of the University of California · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  21. US 11724987

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  22. US 11723992

    Method for extraction and purification of 68GA

    The Board of Regents of the University of Texas System · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  23. US 11723959

    Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptide

    HALOZYME, INC. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  24. US 11723923

    Methods of preparing T cells for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.